About Us | Ascend Genomics

Who Is Ascend Genomics

Ascend Genomics is a CLIA certified and CAP approved, high-complexity cancer reference laboratory dedicated to excellence, innovation and the highest level of service in hematopathology and solid tumor cancer testing.

We are the oncology division of Ascend Clinical, a privately held company that has for over 30 years been a leader in end-stage renal disease testing (ESRD) for independent dialysis centers nationwide.

We offer our customers access to powerful and sophisticated test platforms usually available only at universities, national cancer centers, and high-end reference laboratories. These platforms include immunohistochemistry (IHC), flow cytometry, fluorescence in situ hybridization (FISH) and polymerase chain reaction (PCR).